Showing results (341-350 of 356) with videos related to
Sort By:
Pageof 36
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 15, 2016
Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's diseaseJeong Hoon Hong, Yue Kyung Kim, Jae Seol Park, et al.The American Journal of Cardiology|January 28, 2010
Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials)Seung-Whan Lee, Kook-Jin Chun, Seong-Wook Park, et al.JACC. Cardiovascular Interventions|April 25, 2015
Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch StenosisYoung-Hak Kim, Jae-Hwan Lee, Jae-Hyung Roh, et al.Journal of the American College of Cardiology|October 2, 2010
Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trialDuk-Woo Park, Young-Hak Kim, Sung-Cheol Yun, et al.The American Journal of Cardiology|September 26, 2013
Comparison of Zotarolimus-Eluting stent versus Sirolimus-Eluting stent for de novo coronary artery disease in patients with diabetes mellitus from the ESSENCE-DIABETES II trialGyung-Min Park, Seung-Whan Lee, Seong-Wook Park, et al.JACC. Cardiovascular Interventions|October 25, 2011
Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) TrialDuk-Woo Park, Young-Hak Kim, Hae-Geun Song, et al.Journal of the American College of Cardiology|March 12, 2011
A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trialSeung-Whan Lee, Seong-Wook Park, Young-Hak Kim, et al.Gut and Liver|June 26, 2025
Comparing the Efficacy and Safety of Fexuprazan and Lansoprazole for the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Peptic UlcerSeokchan Hong, Ji Hyeon Ju, Sang-Heon Lee, et al.Circulation|October 8, 2013
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trialCheol Whan Lee, Jung-Min Ahn, Duk-Woo Park, et al.Journal of Clinical Neurology (Seoul, Korea)|July 13, 2012
Comparison between clinical disabilities and electrophysiological values in Charcot-Marie-Tooth 1A patients with PMP22 duplicationYoung Hwa Kim, Hwa Kyung Chung, Kee Duk Park, et al.Pageof 36